KDM1A and cancer: Since the discovery of LSD1 in 2004, many LSD1 inhibitors have been described in literature, acting through covalent or non-covalent mechanism, alone or in combination with other therapeutic agents, to fight cancer and non-cancer diseases (Hojfeldt et al., 2013; Yang et al., 2018).